All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease.

ABSTRACT:

Aims

The rate of all-cause mortality is twofold higher in type 2 diabetes than in the general population. Being able to identify patients with the highest risk from the very beginning of the disease would help tackle this burden.

Methods

We tested whether ENFORCE, an established prediction model of all-cause mortality in type 2 diabetes, performs well also in two independent samples of patients with early-stage disease prospectively followed up.

Results

ENFORCE's survival C-statistic was 0.81 (95%CI: 0.72-0.89) and 0.78 (95%CI: 0.68-0.87) in both samples. Calibration was also good. Very similar results were obtained with RECODe, an alternative prediction model of all-cause mortality in type 2 diabetes.

Conclusions

In conclusion, our data show that two well-esta

SUBMITTER: Copetti M 

PROVIDER: S-EPMC8164049 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature